Literature DB >> 28111098

Carbon Sources Tune Antibiotic Susceptibility in Pseudomonas aeruginosa via Tricarboxylic Acid Cycle Control.

Sylvain Meylan1, Caroline B M Porter2, Jason H Yang2, Peter Belenky3, Arnaud Gutierrez2, Michael A Lobritz4, Jihye Park5, Sun H Kim5, Samuel M Moskowitz6, James J Collins7.   

Abstract

Metabolically dormant bacteria present a critical challenge to effective antimicrobial therapy because these bacteria are genetically susceptible to antibiotic treatment but phenotypically tolerant. Such tolerance has been attributed to impaired drug uptake, which can be reversed by metabolic stimulation. Here, we evaluate the effects of central carbon metabolite stimulations on aminoglycoside sensitivity in the pathogen Pseudomonas aeruginosa. We identify fumarate as a tobramycin potentiator that activates cellular respiration and generates a proton motive force by stimulating the tricarboxylic acid (TCA) cycle. In contrast, we find that glyoxylate induces phenotypic tolerance by inhibiting cellular respiration with acetyl-coenzyme A diversion through the glyoxylate shunt, despite drug import. Collectively, this work demonstrates that TCA cycle activity is important for both aminoglycoside uptake and downstream lethality and identifies a potential strategy for potentiating aminoglycoside treatment of P. aeruginosa infections.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  LC-MS metabolomics; Pseudomonas aeruginosa; TCA cycle; aminoglycoside susceptibility; biochemical persistence; electron transport chain; fumarate; glyoxylate; respiration

Mesh:

Substances:

Year:  2017        PMID: 28111098      PMCID: PMC5426816          DOI: 10.1016/j.chembiol.2016.12.015

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  58 in total

1.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

2.  Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors.

Authors:  Morten Hentzer; Hong Wu; Jens Bo Andersen; Kathrin Riedel; Thomas B Rasmussen; Niels Bagge; Naresh Kumar; Mark A Schembri; Zhijun Song; Peter Kristoffersen; Mike Manefield; John W Costerton; Søren Molin; Leo Eberl; Peter Steinberg; Staffan Kjelleberg; Niels Høiby; Michael Givskov
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

3.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

4.  Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis.

Authors:  D Chambers; F Scott; R Bangur; R Davies; A Lim; S Walters; G Smith; T Pitt; D Stableforth; D Honeybourne
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

5.  Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.

Authors:  Ronald L Gibson; Julia Emerson; Sharon McNamara; Jane L Burns; Margaret Rosenfeld; Ann Yunker; Nicole Hamblett; Frank Accurso; Mark Dovey; Peter Hiatt; Michael W Konstan; Richard Moss; George Retsch-Bogart; Jeffrey Wagener; David Waltz; Robert Wilmott; Pamela L Zeitlin; Bonnie Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2002-12-12       Impact factor: 21.405

6.  Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  María T Andrés; Mónica Viejo-Diaz; Francisco Pérez; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

7.  Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.

Authors:  P K Singh; A L Schaefer; M R Parsek; T O Moninger; M J Welsh; E P Greenberg
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

8.  Inhibition effects of furfural on alcohol dehydrogenase, aldehyde dehydrogenase and pyruvate dehydrogenase.

Authors:  Tobias Modig; Gunnar Lidén; Mohammad J Taherzadeh
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

Review 9.  Pathophysiology and management of pulmonary infections in cystic fibrosis.

Authors:  Ronald L Gibson; Jane L Burns; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2003-10-15       Impact factor: 21.405

10.  Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin.

Authors:  Marshall C Walters; Frank Roe; Amandine Bugnicourt; Michael J Franklin; Philip S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

View more
  97 in total

Review 1.  Pseudomonad reverse carbon catabolite repression, interspecies metabolite exchange, and consortial division of labor.

Authors:  Heejoon Park; S Lee McGill; Adrienne D Arnold; Ross P Carlson
Journal:  Cell Mol Life Sci       Date:  2019-11-25       Impact factor: 9.261

2.  Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.

Authors:  Sandra J Aedo; Juechun Tang; Mark P Brynildsen
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

3.  Promysalin Elicits Species-Selective Inhibition of Pseudomonas aeruginosa by Targeting Succinate Dehydrogenase.

Authors:  Colleen E Keohane; Andrew D Steele; Christian Fetzer; Jittasak Khowsathit; Daria Van Tyne; Lucile Moynié; Michael S Gilmore; John Karanicolas; Stephan A Sieber; William M Wuest
Journal:  J Am Chem Soc       Date:  2018-01-24       Impact factor: 15.419

4.  Drug persistence - from antibiotics to cancer therapies.

Authors:  Karl Kochanowski; Leanna Morinishi; Steven Altschuler; Lani Wu
Journal:  Curr Opin Syst Biol       Date:  2018-03-31

5.  A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.

Authors:  David R Cameron; Yue Shan; Eliza A Zalis; Vincent Isabella; Kim Lewis
Journal:  J Bacteriol       Date:  2018-08-10       Impact factor: 3.490

Review 6.  How innate immunity proteins kill bacteria and why they are not prone to resistance.

Authors:  Roman Dziarski; Dipika Gupta
Journal:  Curr Genet       Date:  2017-08-24       Impact factor: 3.886

7.  L-lysine potentiates aminoglycosides against Acinetobacter baumannii via regulation of proton motive force and antibiotics uptake.

Authors:  Wanyan Deng; Tiwei Fu; Zhen Zhang; Xiao Jiang; Jianping Xie; Hang Sun; Peng Hu; Hong Ren; Peifu Zhou; Qi Liu; Quanxin Long
Journal:  Emerg Microbes Infect       Date:  2020-03-20       Impact factor: 7.163

Review 8.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

9.  Influence of Excipients on the Antimicrobial Activity of Tobramycin Against Pseudomonas aeruginosa Biofilms.

Authors:  Tania Bahamondez-Canas; Hugh D C Smyth
Journal:  Pharm Res       Date:  2018-01-02       Impact factor: 4.200

10.  Membrane voltage dysregulation driven by metabolic dysfunction underlies bactericidal activity of aminoglycosides.

Authors:  Giancarlo Noe Bruni; Joel M Kralj
Journal:  Elife       Date:  2020-08-04       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.